CSL Behring Lengnau AG

Switzerland


 
Total IP 126
Total IP Rank # 10,437
IP Activity Score 2.5/5.0    39
IP Activity Rank # 19,370
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

24 4
6 23
15 15
39
 
Last Patent 2025 - Improved media for the expressio...
First Patent 2015 - Modified von willebrand factor
Last Trademark 2022 - IDELVION
First Trademark 2014 - SOLCHAYN

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Improved media for the expression of recombinant vitamin k-dependent proteins. The present inven...
2023 G/S Pharmaceutical preparations and substances; pharmaceutical products for treatment or prevention ...
2022 Invention Factor ix subcutaneous administration with enhanced safety. This invention relates to Factor IX ...
Invention Factor ix subcutaneous administration with enhanced safety. This invention relates to Factor IX c...
G/S Pharmaceutical products for treatment of blood and coagulation disorders; blood products, namely,...
G/S Pharmaceutical products for treatment of blood and coagulation disorders; blood products; blood ...
2021 G/S Pharmaceutical preparations and substances; pharmaceuticals for the treatment and prevention of ...
2020 Invention Methods for preparing modified von willebrand factor. The present invention provides modified von...
Invention Stable compositions of fc multimers. The disclosure relates inter alia to an Fc multimer composi...
Invention Stable compositions of fc multimers. The invention relates inter alia to an Fc multimer compositi...
Invention Polypeptides for inducing tolerance to factor viii. The present invention relates to polypeptide...
Invention Polypeptides for inducing tolerance to factor viii. The present invention relates to polypeptides...
Invention Recombinant igg fc multimers for the treatment of immune complex-mediated kidney disorders. The ...
Invention Recombinant igg fc multimers for the treatment of immune complex-mediated kidney disorders. The i...
Invention A truncated von willebrand factor (vwf) for increasing the in vitro stability of coagulation fact...
Invention Factor ix variants and uses thereof in therapy. This invention provides Factor IX variants, molec...
2019 Invention Infusion device having a gripper mechanism. An infusion device for a syringe is disclosed. The sy...
Invention Infusion device having a syringe plunger control comprising a joystick. An infusion device is dis...
G/S Pharmaceutical preparations for the treatment of blood disorders and issues with blood coagulatio...
G/S Pharmaceutical products for the treatment of blood and/or coagulation disorders; blood products;...
2018 Invention Protein purification and virus inactivation with alkyl glycosides. A process for purifying a reco...
Invention Recombinant igg fc multimers for the treatment of neuromyelitis optica. This disclosure provides ...
Invention 21-day dosing regimen for fusion proteins comprising factor ix and human albumin for prophylactic...
Invention Immunomodulatory proteins. A method for treatment of a mammalian subject for an autoimmune or in...
Invention Modulation of fviii immunogenicity by truncated vwf. The present invention relates to a recombina...
G/S pharmaceuticals for the treatment or prevention of blood and bleeding disorders; blood products, ...
G/S Pharmaceuticals for the treatment or prevention of blood and bleeding disorders; blood products, ...
G/S Pharmaceuticals for the treatment or prevention of blood and/or bleeding disorders; Blood product...
G/S Pharmaceuticals for the treatment and prevention of blood and bleeding disorders; blood products,...
G/S Computer software for operating infusion pumps; mobile apps for operating infusion pumps; softwar...
2017 Invention Truncated von willebrand factor polypeptides for extravascular administration in the treatment or...
Invention Truncated von willebrand factor polypeptides for treating hemophilia. The invention pertains to a...
G/S Computer software; Software and applications for mobile devices; Mobile apps. Medical apparatus a...
G/S Computer software; Mobile apps; Software and applications for mobile devices. Medical apparatus a...
G/S Computer Software, software and software applications (apps) for mobile devices. Medical apparatu...
G/S Computer software for controlling and managing patient medical information, downloadable mobile s...
G/S Computer software, software and software applications (apps) for mobile devices, used in connecti...
G/S Computer Software, software and software applications (apps) for mobile devices used in connectio...
Invention Subcutaneous administration of long-acting factor ix in humans. The present invention relates to...
Invention Subcutaneous administration of long-acting factor ix in humans. The present invention relates to ...
Invention Recombinant igg fc multimers. This disclosure provides recombinant IgG Fc multimers and methods o...
Invention Mutated von willebrand factor. The present invention provides a modified polypeptide which binds ...
Invention Mutated truncated von willebrand factor. The present invention provides a modified polypeptide wh...
2016 Invention Media for the expression of recombinant vitamin k-dependent proteins. The present invention relat...
Invention Truncated von willebrand factor polypeptides for treating hemophilia. The invention relates to a ...
Invention Syringe pump housing
Invention Modified von willebrand factor having improved half-life. The invention relates to a modified VWF...
Invention Compounds for improving the half-life of von willebrand factor. The invention relates to a compo...
2015 Invention Modified von willebrand factor. The present invention provides a modified polypeptide which binds...